The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer—a pooled analysis of the randomised clinical trials PlanB and SUCCESS C
2022 · British Journal of Cancer · 47 citations
https://doi.org/10.1038/s41416-021-01690-6